FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2070093958> ?p ?o ?g. }

• W2070093958 endingPage "244" @default.
• W2070093958 startingPage "236" @default.
• W2070093958 abstract "Although the medical determinants of mortality in patients with end-stage renal disease (ESRD) treated with hemodialysis (HD) are well appreciated, the contribution of immunologic parameters to survival in such patients is unclear, especially when variations in age, medical comorbidity and nutrition are controlled. In addition, although dysregulation of cytokine metabolism has been appreciated in patients with ESRD, the association of these parameters with outcomes has not been established. Recently, the type of dialyzer used in patients' treatment has been associated with survival, but the mechanisms underlying these findings, including their immune effects, have not been established. We conducted a prospective, cross-sectional, observational multicenter study of urban HD patients to determine the contribution of immunological factors to patient survival. We hypothesized increased proinflammatory cytokines would be associated with increased mortality, and that improved immune function would be associated with survival.Patients were assessed using demographic and anthropometric indices, Kt/V, protein catabolic rate (PCR) and immunologic variables including circulating cytokine [interleukin (IL)-1, IL-2, IL-4, IL-5, IL-6, IL-12, IL-13 and tumor necrosis factor (TNF)-alpha] levels, total hemolytic complement activity (CH50), and T cell number and function. A severity index, previously demonstrated to be a mortality marker, was used to grade medical comorbidity. A Cox proportional hazards model, controlling for patients' age, severity index, level of serum albumin concentration, dialyzer type and dialysis site was used to asses relative survival risk.Two hundred and thirty patients entered the study. The mean (+/- SD) age of the population was 54.4 +/- 14.2 years, mean serum albumin concentration was 3.86 +/- 0.47 g/dl, mean PCR was 1.1 +/- 0.28 g/kg/day, and mean Kt/V 1.2 +/- 0.3. Patients' serum albumin concentration was correlated with levels of Kt/V and PCR, and their circulating IL-13 and TNF-alpha levels, but negatively with their circulating IL-2 levels, T-cell number and T-cell antigen recall function. T-cell antigen recall function correlated negatively with PCR, but not Kt/V. There was no correlation of any other immune parameter and medical or demographic factor. Immune parameters, were all highly intercorrelated. Mean level of circulating cytokines in HD patients were in all cases greater than those of a normal control group. There were few differences in medical risk factors or immune parameters between patients treated with different types of dialyzers. After an almost three-year mean follow-up period, increased IL-1, TNF-alpha, IL-6, and IL-13 levels were significantly associated with increased relative mortality risk, while higher levels of IL-2, IL-4, IL-5, IL-12, T-cell number and function, and CH50 were associated with improved survival. The difference in survival between patients treated with unmodified cellulose dialyzers and modified or synthetic dialyzers approached the level of statistical significance, but there were no differences in levels of circulating cytokines between these two groups.Higher levels of circulating proinflammatory cytokines are associated with mortality, while immune parameters reflecting improved T-cell function are associated with survival in ESRD patients treated with HD, independent of other medical risk factors. These factors may serve as markers for outcome. The mechanism underlying the relationship of immune function and survival, and the effect of interventions to normalize immune function in HD patients should be studied." @default.
• W2070093958 created "2016-06-24" @default.
• W2070093958 creator A5003564019 @default.
• W2070093958 creator A5004166896 @default.
• W2070093958 creator A5035853275 @default.
• W2070093958 creator A5040623960 @default.
• W2070093958 creator A5055463479 @default.
• W2070093958 creator A5068075323 @default.
• W2070093958 creator A5075115334 @default.
• W2070093958 creator A5084151522 @default.
• W2070093958 creator A5086440149 @default.
• W2070093958 date "1998-07-01" @default.
• W2070093958 modified "2023-10-17" @default.
• W2070093958 title "Immunologic function and survival in hemodialysis patients" @default.
• W2070093958 cites W1847168837 @default.
• W2070093958 cites W1893499751 @default.
• W2070093958 cites W1917015190 @default.
• W2070093958 cites W1964185260 @default.
• W2070093958 cites W1983523234 @default.
• W2070093958 cites W1986208951 @default.
• W2070093958 cites W1989940837 @default.
• W2070093958 cites W2004435767 @default.
• W2070093958 cites W2008854521 @default.
• W2070093958 cites W2009730157 @default.
• W2070093958 cites W2019876882 @default.
• W2070093958 cites W2020354584 @default.
• W2070093958 cites W2031268915 @default.
• W2070093958 cites W2032625253 @default.
• W2070093958 cites W2032655768 @default.
• W2070093958 cites W2048779896 @default.
• W2070093958 cites W2058161128 @default.
• W2070093958 cites W2067964757 @default.
• W2070093958 cites W2081385953 @default.
• W2070093958 cites W2087417466 @default.
• W2070093958 cites W2090887756 @default.
• W2070093958 cites W2123000394 @default.
• W2070093958 cites W2133406706 @default.
• W2070093958 cites W2148080316 @default.
• W2070093958 cites W2148883692 @default.
• W2070093958 cites W2167311298 @default.
• W2070093958 cites W2325491525 @default.
• W2070093958 cites W2333333141 @default.
• W2070093958 cites W2341277428 @default.
• W2070093958 cites W2905431479 @default.
• W2070093958 cites W4376595416 @default.
• W2070093958 cites W46168485 @default.
• W2070093958 doi "https://doi.org/10.1046/j.1523-1755.1998.00981.x" @default.
• W2070093958 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6146918" @default.
• W2070093958 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9648084" @default.
• W2070093958 hasPublicationYear "1998" @default.
• W2070093958 type Work @default.
• W2070093958 sameAs 2070093958 @default.
• W2070093958 citedByCount "465" @default.
• W2070093958 countsByYear W20700939582012 @default.
• W2070093958 countsByYear W20700939582013 @default.
• W2070093958 countsByYear W20700939582014 @default.
• W2070093958 countsByYear W20700939582015 @default.
• W2070093958 countsByYear W20700939582016 @default.
• W2070093958 countsByYear W20700939582017 @default.
• W2070093958 countsByYear W20700939582018 @default.
• W2070093958 countsByYear W20700939582019 @default.
• W2070093958 countsByYear W20700939582020 @default.
• W2070093958 countsByYear W20700939582021 @default.
• W2070093958 countsByYear W20700939582022 @default.
• W2070093958 countsByYear W20700939582023 @default.
• W2070093958 crossrefType "journal-article" @default.
• W2070093958 hasAuthorship W2070093958A5003564019 @default.
• W2070093958 hasAuthorship W2070093958A5004166896 @default.
• W2070093958 hasAuthorship W2070093958A5035853275 @default.
• W2070093958 hasAuthorship W2070093958A5040623960 @default.
• W2070093958 hasAuthorship W2070093958A5055463479 @default.
• W2070093958 hasAuthorship W2070093958A5068075323 @default.
• W2070093958 hasAuthorship W2070093958A5075115334 @default.
• W2070093958 hasAuthorship W2070093958A5084151522 @default.
• W2070093958 hasAuthorship W2070093958A5086440149 @default.
• W2070093958 hasBestOaLocation W20700939581 @default.
• W2070093958 hasConcept C126322002 @default.
• W2070093958 hasConcept C159641895 @default.
• W2070093958 hasConcept C164027704 @default.
• W2070093958 hasConcept C203014093 @default.
• W2070093958 hasConcept C2776914184 @default.
• W2070093958 hasConcept C2778063415 @default.
• W2070093958 hasConcept C2779159551 @default.
• W2070093958 hasConcept C2779978075 @default.
• W2070093958 hasConcept C2908647359 @default.
• W2070093958 hasConcept C50382708 @default.
• W2070093958 hasConcept C71924100 @default.
• W2070093958 hasConcept C90924648 @default.
• W2070093958 hasConcept C99454951 @default.
• W2070093958 hasConceptScore W2070093958C126322002 @default.
• W2070093958 hasConceptScore W2070093958C159641895 @default.
• W2070093958 hasConceptScore W2070093958C164027704 @default.
• W2070093958 hasConceptScore W2070093958C203014093 @default.
• W2070093958 hasConceptScore W2070093958C2776914184 @default.
• W2070093958 hasConceptScore W2070093958C2778063415 @default.
• W2070093958 hasConceptScore W2070093958C2779159551 @default.
• W2070093958 hasConceptScore W2070093958C2779978075 @default.
• W2070093958 hasConceptScore W2070093958C2908647359 @default.

• next